Quiz 2 Flashcards

1
Q

Perioperative HTN - Primary cause: Increased _________ discharge with systemic vasoconstriction

A

sympathetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Perioperative Hypertension Complications:

A
  • CVA
  • MI
  • ischemia
  • LV dysfunction
  • arrhythmias
  • increased suture tension
  • hemorrhage
  • pulmonary edema
  • cognitive dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hemodynamic Effects of vasodilators

A

Reflex increase in HR (Baroreceptors) pure

Redistribution of coronary blood flow

  • NTG may improve collateral circulation
  • Others may cause coronary steal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hydralazine (apresoline)

A
  • Direct acting arterial vasodilator
  • Inc HR, contractility, renin activity, fluid retention, CO, SV
  • Dec BP (diastolic > systolic) and SVR
  • Has own receptor referred to as hydralazine receptor – cGMP pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Avoid hydralazine in patients with?

A
  • CAD
  • Increased ICP
  • Lupus

(Increases myocardial oxygen demand )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hydralazine S/S

A
  • paralytic ileus
  • Anemia
  • aganulocytosis
  • muscle cramps
  • edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hydralazine onset

A

30 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hydralazine advantages

A
  • Maintains/increases cerebral blood flow

- increased CO and SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nitroglycerine

A
  • Causes a release of nitric oxide for non-specific relaxation of the vascular smooth muscle
  • Dilates veins > arteries
  • Dec PVR, venous return, myocardial oxygen consumption
  • Relaxes coronary vessels and relieves spasms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-cardiac Effects of NTG

A
  • Dilates meningeal vessles (caution with inc ICP)
  • Dec renal blood flow with dec BP
  • Dilates pulmonary vessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NTG onset

A

1 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NTG Metabolism/Tolerance

A

Metabolized by glutathione nitrate reductase in the liver

Nitrite ion oxidizes Hgb to methemoglobin

Tolerance in arterial vessels can occur with chronic administration but not in the venous vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NTG S/S

A
  • Headache (most common)
  • Postural hypotension
  • Methemoglobinemia
  • anaphylaxis
  • oral and conjunctival edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NTG Warnings/Contraindications

A
  • PDE5 inhibitors viagara, Cialis – profound hypoTN
  • Narrow angle glaucoma
  • Head trauma, cerebral hemorrhage
  • Severe anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nitroprusside

A
  • Inc cerebral blood flow and ICP
  • Renal blood flow: maintained, slight reduction
  • Overall reduction in myocardial O2 demand
  • With abrupt discontinuation: reflex tachycardia and hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

odd about kinetics of Nitroprusside

A

Half-life can be as long as 7 days d/t compound build up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Nitroprusside S/S

A
  • retrosternal discomfort
  • thiocyanate/cyanide toxicity
  • Increased Cr
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nitroprusside Warnings/Contraindications

A
  • Congenital optic atrophy
  • Hypovolemia
  • Compensatory HTN (AV shunting, aortic coarctation)
  • Inc ICP
  • Severe renal/hepatic impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Thiocyanate/Cyanide Toxicity S/S

A
  • Hypotension
  • blurred vision
  • fatigue
  • metabolic acidosis
  • pink skin
  • absence of reflexes
  • faint heart sounds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Thiocyanate/Cyanide Toxicity Increased risk

A
  • doses over 4 mcg/kg/min

- > 2 days of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thiocyanate/Cyanide levels

A

Thiocyanate:

  • Therapeutic 6-29 mcg/mL
  • Fatal: >200 mcg/mL

Cyanide

  • Toxic: > 2 mcg/mL
  • Fatal: > 3 mcg/mL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Treatment of Cyanide Toxicity

A
  • Stop infusion
  • Administer 100% oxygen
  • Correct metabolic acidosis
  • Administer 3% sodium nitrite 4-6 mg/kg slowly IV
  • Administer sodium thiosulfate 150-200 mg/kg IV over 15 min breaks down cyanide
  • Consider Vitamin B12 25 mg/hr
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which nonselective alpha antagonist irreversibly binds to the receptor?

A

Phenoxybenzamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Phenoxybenzamine use

A
  • Long-term preoperative treatment to control the effects of pheochromocytoma (“chemical sympathectomy”)
  • Relieve ischemia in PVD
  • BPH to improve flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Phenoxybenzamine

A
  • Reduced PVR to reduced BP
  • Secondary increases in NE due to alpha 2 blockade can increase HR and CO
  • Crosses the BBB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Phentolamine uses

A
  • Hypertension secondary to pheochromocytoma
  • Clonidine withdrawal hypertension
  • Erectile dysfunction
  • Extravasation of catecholamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Oral Alpha 1 Antagonists for BPH

A

“-osin’s”

Might not give effect you want from giving alpha agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Alpha 2 Agonists and Cardiac Complications

A

Reduce cardiac complications: Cochrane Review

  • Overall mortality
  • Cardiac mortality
  • MI

Vascular Surgery especially beneficial

29
Q

Clonidine

A
  • Decreases HR, BP, C.O., and SVR (Baroreceptors reflexes are preserved)
  • Abrupt cessation of drug may lead to rebound hypertension (at risk if using for at least 6 days)
30
Q

Why do you get rebound HTN after abrupt cessation of Clonidine? Treatment?

A

Due to NE upregulation of receptors

Need combined alpha/beta blocker (labetalol/coreg)

31
Q

How long does clonidine patch take?

A

2 days to reach full potential

32
Q

Clonidine: effects on anesthesia

A
  • Reduces propofol and thiopental requirements
  • Alternative to N2O for shortening induction time and attenuating the adrenergic response to intubation during inhaled anesthesia
  • Supplement of regional blocks
33
Q

Which has a higher affinity for Alpha 2 receptors, clonidine or Precidex?

A

Precidex (1620:1 vs 220:1)

34
Q

Dexmedetomidine S/S

A

-Nausea/vomiting, Fever, Hypoxia

Bolus:
-Hypertension.*
-Bradycardia.
(Clinically significant bradycardia and sinus arrest in young, healthy volunteers with high vagal tone.*)

Infusion:
-Hypotension

35
Q

Look at slide 58

A

.

36
Q

Methyldopa use

A

HTN in 3rd trimester

37
Q

Methyldopa S/S

A
  • Fluid retention
  • Positive Coombs test
  • hemolytic anemia
  • bone marrow suppression
  • impotence
38
Q

A.C.E. Inhibitors

A
  • Predominantly arterial vasodilators
  • Treat CHF and MR by afterload reduction
  • Increase CO without excessive decrease in preload
39
Q

ACEs best in _______ pt due to renal protection

A

diabetic

40
Q

Look at slide 65

A

.

41
Q

Most end in “-pril”

A

ACE inhibitors

42
Q

ACE Inhibitors S/S

A
  • Cough, congestion, and rhinorrhea most common side effects
  • Angioedema serious side effect
  • Safe to DC w/o taper
43
Q

Cough due to increased ________ in the lungs, does not go away unless changing med to ARB or similar

A

bradykinin

44
Q

A.C.E. Inhibitors caution with

A
  • ARF and hyper K+

- Do NOT use at all during pregnancy

45
Q

“-sartans”

A

ARBs (less cough/angioedema than ACEIs)

46
Q

Calcium Channel Blockers effects

A
  • Negative Inotropic effect
  • Negative dromotropic effect (AV conduction block)
  • Vasodilation of systemic, splanchnic, coronary and pulmonary beds
47
Q

phenylalkylamines

A

verapamil

48
Q

benzothiazines

A

diltiazem

49
Q

Dihydropyridines

A

“-dipines” (pure atrial dilators)

50
Q

verapamil, used for

A

Potent negative inotrope, dromotrope and vasodilator

Used for:

  • Aortic Stenosis and IHSS
  • Conversion of atrial re-entry tachyarrhythmias
  • Coronary artery vasospasm (Prinzmetal angina
51
Q

Verapamil S/S

A
  • Constipation

- lower extremity edema

52
Q

Look at slide 89

A

.

53
Q

CCBs S/S

A

Arthralgias/joint stiffness, itching

54
Q

Which CCBs better at reducing workload on heart

A

Verapamil and Diltiazem

55
Q

May potentiate the effects of neuromuscular blocking agents

A

CCBs

56
Q

_________ reduces gastric emptying

A

Clevidipine

57
Q

_______ increases sedative effects of midazolam

A

Diltiazem - increased DOA

58
Q

Beta Blockers actions

A
  • Decrease C.O. (HR and contractility)

- Decrease renin release

59
Q

Beta blockers advantages over vasodilators

A
  • No reflex tachycardia or widening of pulse pressure
  • Improved MvO2 (decrease HR and decrease contractility)
  • Intrinsic antiarrhythmic activity
60
Q

Non-selective Beta blockers

A

Propranolol, Nadolol, Timolol, Pindolol, Carteolol

61
Q

Look at slide 102-103

A

.

62
Q

BBlockers S/S

A

Non-selective blockade of Beta-2 receptors

  • Vasoconstriction and worsening PVD
  • Bronchospasm

Myocardial depression
-Decreased contractility could precipitate CHF

Life-threatening bradycardia or asystole

Hyperkalemia in renal failure*

63
Q

Caution when using with Verapamil, Digoxin. Why?

A
  • Verapamil (decrease HR and contractility)

- Digoxin (decrease HR and conduction)

64
Q

BBlocker O/D treatment

A
  • Treat with atropine
  • May need Isoproterenol, dobutamine and/or glucagon infusion
  • Could ultimately need pacing
65
Q

BBlockers contraindications

A
  • Severe bradycardia
  • > 1st degree heart block
  • Cardiogenic shock
  • Raynaud’s disease

Caution

  • Asthma/COPD
  • Diabetes can cause hyperglycemia or mask hypoglycemia
  • Heart failure
66
Q

Labetalol

A

Combines weak Alpha blockade with weak non-selective Beta blockade

67
Q

BBlocker caution

A

Do not stop abruptly due to rebound hypertension and tachycardia

Anticholinesterases may increase bradycardia

68
Q

Look at slide 120

A

.

69
Q

Look at slide 123

A

.